White & Case advised Neopharmed Gentili. Linklaters acted for the syndicate of placing banks led by BNP Paribas and for the holders of Neon Midco’s PIK...
Neopharmed Gentili Places €890 Million High-Yield Bond
Neopharmed Gentili Secures European Rights to Navenibart from BioCryst Pharmaceuticals
White & Case has advised Neopharmed Gentili S.p.A. on its licensing agreement with BioCryst Pharmaceuticals, Inc. Neopharmed Gentili S.p.A., through its Irish affiliate, has entered into...
BioCryst Sells European ORLADEYO® Business to Neopharmed Gentili for Up to $264 Million
Skadden has advised BioCryst Pharmaceuticals, Inc., White & Case has advised Neopharmed Gentili. BioCryst Pharmaceuticals, Inc. has announced the execution of a definitive agreement for the...
Neopharmed Gentili S.p.A. (Ardian)’s Acquisition Of Valeas S.p.A.
White & Case advised the sellers, while Neopharmed Gentili S.p.A. was advised by Giovannelli e Associati, Gitti and Partners and Gattai, Minoli, Partners. Latham & Watkins...
Neopharmed Gentili S.p.A.’s Acquisition Of Rights Of Brand Minias, Noctamid And Evamyl
IN BRIEF: Giovannelli e Associati Studio Legale, Gitti and Partners, Loeschner Rechtsanwaltsgesellschaft mbH, Vasco da Gama, advised on the matter. Giovannelli e Associati Studio Legale advised...